Curt joined NuQuatic as the Chief Operating Officer in 2023 to lead the development and validation of technologies. Prior to joining NuQuatic, Curt spent 35 years in the environmental consulting industry with the last 30 years with Arcadis. During his tenure at Arcadis, he served in a wide variety of operational and technical roles within North America, including leading the technical knowledge and innovation function that was responsible for developing new technologies and the professional talent to execute complex projects. He later served as the North American President for environment before transitioning to a Global performance improvement role to transfer best practices into operations globally. Curt holds a BS in Geology from Allegheny College and is a professional geologist.

Dr. Charlie Cooper is Chief Technology Officer at Nuquatic, where he leads the development and commercialization of advanced water treatment technologies with a focus on PFAS removal and destruction. He brings over 25 years of experience in process engineering, technology development, and scaling complex systems from concept to deployment.

Prior to Nuquatic, Dr. Cooper was General Manager of the Illinois Accelerator Research Center at Fermi National Accelerator Laboratory, where he led multidisciplinary teams in advancing novel technologies for real-world applications. His work positioned him as a recognized leader in PFAS treatment, including the development of electron beam-based destruction technologies and other innovative approaches for managing emerging contaminants.

Dr. Cooper has secured and led multi-million-dollar programs, authored 40+ technical publications, and holds patents in advanced processing technologies. He holds a Ph.D. in Chemical Engineering from the University of Cincinnati and an Executive MBA from the University of Chicago Booth School of Business.

Dr. Borras joined NuQuatic in 2018 and leads the core science and technology development at NuQuatic. He is the primary inventor on NuQuatic’s galvanic and electrolytic patent portfolio. Dr. Borras has over 25 years of experience in Electrochemistry, including 15+ years at Simon Bolivar University in Venezuela as Professor of Electrochemistry and Dean of Students. Dr. Borras is considered the original thought leader on the topics of electrochemical oxidation of organic materials and conceptual electrochemical cell design. Leading researchers cite Dr. Borras’s previous work and publications as a contributing basis for current research efforts on the topic of electrochemical oxidation of PFAS and other organic contaminants

Kyle joined NuQuatic in 2024 as Lead Engineer, focused on providing engineering and project management leadership and world-class service to NuQuatic’s customers. Prior to NuQuatic, Kyle spent 4 years as a Senior Project Manager and Engineering Manager with Xylem’s water and wastewater treatment division, where he led a multi-disciplinary team that provided custom, engineered-to-order equipment designs. At Xylem, Kyle also oversaw all engineering design work for a 15-person team spread across the US and India. Additionally, Kyle brings substantial water-related project management and engineering consultancy experience from 7 years with GRAEF. Kyle holds a BS in Civil Engineering from The University of Wisconsin Milwaukee and is a licensed Professional Engineer in the State of Wisconsin.

Dr. Levy joined NuQuatic in 2026 and leads our internal LCMS analysis for PFAS as well as analytical chemistry efforts at NuQuatic. Prior to NuQuatic, Dr. Levy worked as an LCMS Senior Scientist at Idexx Laboratories doing proteomics biomarker discovery for veterinary diagnostics, and she was a NRC Post-Doctoral Fellow at the Air Force Research Laboratory in Dayton Ohio. She has experience analyzing small synthetic molecules and biological molecules of various sizes, including metabolites, lipids, and proteins.

She is experienced in LCMS method development and optimization for both triple quadrupole and high-resolution mass spectrometry systems such as used for PFAS analysis. She is also experienced in liquid-based separations including HPLC, UPLC, and offline fractionation; as well as additional front end separation methods such as ion mobility and capillary electrophoresis. Further, Dr. Levy is well versed in various sample preparation techniques including solid phase extraction, liquid-liquid extraction, immunoprecipitation, ultracentrifugation, and protein digestion. Dr. Levy holds a Ph. D. in analytical chemistry with a focus in mass spectrometry from the University of Florida.

Nadine joined NuQuatic directly after graduating from University of South Florida in 2022 with a Bachelor of Science in Chemical Engineering, Nadine has been involved with conducting treatability experiments testing the ADVANTAGE™ Process from its early development stages through client demonstrations in the lab and field. She is currently involved with experimentation, design, and operation of NuQuatic’s in-house and mobile treatment units. This deep experience is currently being leveraged into the design of field and full-scale systems.